Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CICLOSPORIN Cause Acute graft versus host disease? 41 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Acute graft versus host disease have been filed in association with CICLOSPORIN. This represents 8.6% of all adverse event reports for CICLOSPORIN.

41
Reports of Acute graft versus host disease with CICLOSPORIN
8.6%
of all CICLOSPORIN reports
21
Deaths
1
Hospitalizations

How Dangerous Is Acute graft versus host disease From CICLOSPORIN?

Of the 41 reports, 21 (51.2%) resulted in death, 1 (2.4%) required hospitalization.

Is Acute graft versus host disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CICLOSPORIN. However, 41 reports have been filed with the FAERS database.

What Other Side Effects Does CICLOSPORIN Cause?

Drug ineffective (74) Foetal exposure during pregnancy (63) Low birth weight baby (57) Premature baby (54) Cytomegalovirus infection (28) Renal impairment (26) Hypertension (24) Pyrexia (23) Blood creatinine increased (22) Blood pressure increased (22)

What Other Drugs Cause Acute graft versus host disease?

CYCLOSPORINE (1,043) MYCOPHENOLATE MOFETIL (1,021) FLUDARABINE (715) CYCLOPHOSPHAMIDE (710) TACROLIMUS (686) METHOTREXATE (656) BUSULFAN (337) THIOTEPA (331) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (245) RUXOLITINIB (240)

Which CICLOSPORIN Alternatives Have Lower Acute graft versus host disease Risk?

CICLOSPORIN vs CIDOFOVIR CICLOSPORIN vs CILASTATIN CICLOSPORIN vs CILASTATIN\IMIPENEM CICLOSPORIN vs CILAZAPRIL ANHYDROUS CICLOSPORIN vs CILGAVIMAB\TIXAGEVIMAB

Related Pages

CICLOSPORIN Full Profile All Acute graft versus host disease Reports All Drugs Causing Acute graft versus host disease CICLOSPORIN Demographics